[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Kymera Therapeutics, Inc. Common Stock (KYMR)

Kymera Therapeutics sees increased social engagement and insider buying. Despite a slight price correction, positive sentiment remains high, driven by STAT6 program and analyst ratings.

About Kymera Therapeutics, Inc. Common Stock

Kymera Therapeutics, Inc. (KYMR) is a biopharmaceutical company focused on developing protein degradation therapies.
Kymera Therapeutics, Inc. Common Stock uses the ticker $KYMR for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

Kymera Therapeutics, Inc. Common Stock (KYMR) social dominance is up XXXXX% from the previous week.

Price: $XXXXX #

Price 24-Hour Chart Data
Despite a slight price decrease of -XXXX% in the last XX hours, positive sentiment and insider buying suggest a minor correction. The high sentiment and insider buying are likely to continue to drive the price up.

24-Hour	7-Day	30-Day
-XXXX%	-XXXX%	XXXX%

1-Year High: $XXXXX on 2024-09-24
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
Kymera Therapeutics, Inc. Common Stock (KYMR) is currently AltRank #1,348 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +848
1 Month: XXXXX -XXX
6 Months: XXXXX +627
1 Year: XXXXX +370
1-Year High: XXXXX on 2025-05-27
1-Year Low: XX on 2024-08-24

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +3
1 Month: XX -XX
6 Months: XX +22
1 Year: XX +9
1-Year High: XX on 2025-01-14
1-Year Low: XX on 2024-11-16

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +30%
1 Year: XXXXXXXXX +82%
1-Year High: XXXXXXX on 2025-06-02
1-Year Low: XXX on 2025-03-30

Social Network	X	YouTube
Engagements	XXXXX	X

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +449%
6 Months: XXXXX +147%
1 Year: XXXXX +681%
1-Year High: XXXXX on 2025-07-06
1-Year Low: XX on 2024-09-14

Social Network	X	YouTube
Mentions	XXX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Kymera Therapeutics, Inc. Common Stock (KYMR) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +496%
6 Months: XXXXX +192%
1 Year: XXXXX +769%
1-Year High: XXX on 2025-07-06
1-Year Low: X on 2025-01-27

The most influential creators that mention Kymera Therapeutics, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Andre_AGTC	X	XXXXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -X%
6 Months: XX% +69%
1 Year: XX% +48%
1-Year High: XXX% on 2024-07-30
1-Year Low: XX% on 2025-02-09

Most Supportive Themes

STAT6 Inhibitors and Partnerships: (45%) Kymera's STAT6 program, potential partnerships, and clinical trial data are generating positive sentiment and mentions on social media.
Analyst Ratings and Price Targets: (25%) Bullish analyst ratings and high price target potential are attracting investors, which is reflected in recent social media posts.
Excitement for R&D and Immunology Targets: (15%) Enthusiasm for Kymera's R&D efforts, particularly in immunology targets, is creating positive discussions and engagement.

Most Critical Themes

Timeline Concerns: (5%) Concerns about the timeline for clinical trials related to the Sanofi partnership programs.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXX	XX%	XX	X%
YouTube	X	X%	X	X%	X	X%

Total	XXX	XX%	XXX	XX%	XX	X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.0007499999999999998%
1 Month: XXXXXX% -XXXXX%
6 Months: XXXXXX% +0.0017%
1 Year: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
1-Year High: XXXXX% on 2025-07-06
1-Year Low: XXXXXX% on 2024-07-31

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-02
1-Year Low: XXXXXXX% on 2025-03-19

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$0.84%
1 Month: $XXXXXXXXXXXXX +$0.18%
6 Months: $XXXXXXXXXXXXX +$20%
1 Year: $XXXXXXXXXXXXX +$12%
1-Year High: $XXXXXXXXXXXXX on 2024-09-24
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Kymera Therapeutics, Inc. Common Stock in the last XX hours

BridgeBio Pharma, Inc. Common Stock (BBIO) Cipher Mining Inc. Common Stock (CIFR) Synthetify (SNY) Gilead Sciences, Inc. (GILD) Akropolis (AKRO) Neurocrine Biosciences, Inc. (NBIX) Eli Lilly and Company (LLY) Alnylam Pharmaceuticals, Inc. (ALNY) Insmed, Inc. (INSM)

Top topics mentioned In the posts about Kymera Therapeutics, Inc. Common Stock in the last XX hours

amzn, qqq, $cdtx, nvda, spx, shen, $nrix, $ptn, serv, alt, aes, nrix, $ppta, $qntm, $cogt, hims, hood, akro, prob, onc, $bbio, mor, $mor, googl, yala, rna, bmnr, $cifr, $sny, $gild, threshold, sdm, balance sheet, artl, $wve, $imcr, $akro, $veon, $hnsa, phat, $nbix, scs, $lly, tern, ltc, $asnd, $argx, $nktr, ndx, $alny, $fsm, $crvs, $bcda, lmt, pltr, ptn, $insm, $mlys, $rare, $abcl, $knsa, $bcyc, meta, $morf, $actu, pstv, cfr, $abeo, $mirm, $500m, $mck, $tern, $ltc, gme, $fgbi, $glue, $cccc, $mygn, $iron, coins ai, $netd, $ai, honour, stocks healthcare, $25b, $77m, $730m, gilead sciences, trda, agx, stocks, $futu, cns, $axsm, imo, $raade, $amrn, amgn, $urgn, $rgnx